This trial will test if a new cancer treatment can be given safely to patients outside of a hospital.
2 Primary · 4 Secondary · Reporting Duration: at 30 days
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Vital sign measurements · No Placebo Group · N/A
Age 18 - 75 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: